Low-dose of Aspirin May Reduce Amyloid Plaques in the Brain

Low-dose aspirin may help removal of harmful amyloid plaque in the brain which may reduce the risk of Alzheimer's disease and protect memory.

Low-dose aspirin may reduce harmful amyloid plaques in the brain and lower Alzheimer's disease risk, reports a new study. The findings of the study are published in The Journal of Neuroscience.//

"The results of our study identifies a possible new role for one of the most widely used, common, over-the-counter medications in the world," said Kalipada Pahan, PhD, the study's senior author and lead research investigator, who also is the Floyd A. Davis, MD, Endowed Chair of Neurology and professor of neurological sciences, biochemistry and pharmacology in Rush Medical College.

Taking Aspirin Before and After Coronary Artery Bypass may Enhance Survival
Taking aspirin before and after coronary artery bypass graft (CABG) surgery is associated with reduced mortality risk after four years. Preoperative and postoperative uses of aspirin are defined as within five days preceding surgery and continuously on discharge respectively.

‘Low-dose aspirin may help removal of harmful amyloid plaque in the brain which can reduce the risk of Alzheimer's disease and protect memory.’

Alzheimer's disease is a fatal form of dementia that affects up to 1 in 10 Americans age 65 or older. To date, the FDA has approved very few drugs for the treatment of Alzheimer's disease-related dementia and the medications that exist can only provide limited symptomatic relief.

The exact cause of Alzheimer's disease progression is unknown; however, poor disposal of the toxic protein amyloid beta in the brain is a leading mechanism in dementia and memory loss.

Activating the cellular machinery responsible for removing waste from the brain therefore has emerged as a promising strategy for slowing Alzheimer's disease.

Aspirin may Influence Heart Problems After Normal Surgery
Previous stent or angioplasty patients can experience heart problems after a normal surgery with peri-operative aspirin therapy

Amyloid beta forms clumps called amyloid plaques, which harm connections between nerve cells and are one of the major signs of Alzheimer's disease. Building on previous studies demonstrating a link between aspirin and reduced risk and prevalence of Alzheimer's disease.

Pahan and his colleagues were able to show that aspirin decreases amyloid plaque pathology in mice by stimulating lysosomes -- the component of animal cells that help clear cellular debris.

Aspirin to the Rescue for People With Diabetes and Heart Failure
An aspirin every day lowers the risk of death and hospitalization due to heart failure in patients with diabetes and heart failure.

"Understanding how plaques are cleared is important to developing effective drugs that stop the progression of Alzheimer's disease," said Pahan.

A protein called TFEB is considered the master regulator of waste removal. The researchers gave aspirin orally for a month to genetically modified mice with Alzheimer's pathology, then evaluated the amount of amyloid plaque in the parts of the brain affected most by Alzheimer's disease.

Cancer Fighting Effects of Aspirin
Taking aspirin blocks a key process that is associated with tumor formation, shows new study.

They found that the aspirin medications augmented TFEB, stimulated lysosomes and decreased amyloid plaque pathology in the mice.

"This research study adds another potential benefit to aspirin's already established uses for pain relief and for the treatment of cardiovascular diseases," said Pahan. "More research needs to be completed, but the findings of our study has major potential implications for the therapeutic use of aspirin in AD and other dementia-related illnesses."

Source-Eurekalert